{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:34Z","timestamp":1787800834875,"version":"build-2784847793"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIA K76","award":["AG083286"],"award-info":[{"award-number":["AG083286"]}]},{"DOI":"10.13039\/100007827","name":"American College of Gastroenterology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007827","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn\u2019s and Colitis Foundation","doi-asserted-by":"crossref","award":["878246"],"award-info":[{"award-number":["878246"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Judith & Stewart Colton Center for Autoimmunity"},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK124570"],"award-info":[{"award-number":["K23DK124570"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10620-026-09951-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:52:52Z","timestamp":1777971172000},"page":"4211-4220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of Obesity as an Independent Risk Factor for Colorectal Dysplasia Development in Inflammatory Bowel Disease: A Matched Case\u2013Control Study"],"prefix":"10.1007","volume":"71","author":[{"given":"Naveena","family":"Luke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahnavi","family":"Udaikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Delau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Faye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Axelrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"9951_CR1","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1056\/NEJMra1403718","volume":"372","author":"L Beaugerie","year":"2015","unstructured":"Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441\u20131452. https:\/\/doi.org\/10.1056\/NEJMra1403718.","journal-title":"N Engl J Med."},{"key":"9951_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2021.08.010","volume":"93","author":"AM Wijnands","year":"2021","unstructured":"Wijnands AM, Mahmoud R, Lutgens MWMD, Oldenburg B. Surveillance and management of colorectal dysplasia and cancer in inflammatory bowel disease: Current practice and future perspectives. Eur J Intern Med. 2021;93:35\u201341. https:\/\/doi.org\/10.1016\/j.ejim.2021.08.010.","journal-title":"Eur J Intern Med."},{"key":"9951_CR3","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.cgh.2024.01.030","volume":"22","author":"JE Axelrad","year":"2024","unstructured":"Axelrad JE, Rubin DT. The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2024;22:1181\u20131185. https:\/\/doi.org\/10.1016\/j.cgh.2024.01.030.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9951_CR4","doi-asserted-by":"publisher","unstructured":"Axelrad JE, Shah SC. Diagnosis and management of inflammatory bowel disease-associated neoplasia: considerations in the modern era.\u00a0Therap Adv Gastroenterol. 2020;13:1756284820920779. Published 2020 May 6. https:\/\/doi.org\/10.1177\/1756284820920779","DOI":"10.1177\/1756284820920779"},{"key":"9951_CR5","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/ibd\/izaf098","volume":"31","author":"J Sun","year":"2025","unstructured":"Sun J, Brooks EC, Houshyar Y et al. Unravelling the Relationship Between Obesity and Inflammatory Bowel Disease. Inflamm Bowel Dis. 2025;31:2547\u20132560. https:\/\/doi.org\/10.1093\/ibd\/izaf098.","journal-title":"Inflamm Bowel Dis."},{"key":"9951_CR6","doi-asserted-by":"publisher","unstructured":"Al Sulais E, AlAmeel T, Alenzi M, Shehab M, AlMutairdi A, Al-Bawardy B. Colorectal Neoplasia in Inflammatory Bowel Disease.\u00a0Cancers (Basel). 2025;17(4):665. Published 2025 Feb 16. https:\/\/doi.org\/10.3390\/cancers17040665","DOI":"10.3390\/cancers17040665"},{"key":"9951_CR7","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3322\/caac.21499","volume":"69","author":"H Sung","year":"2019","unstructured":"Sung H, Siegel RL, Torre LA et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin. 2019;69:88\u2013112. https:\/\/doi.org\/10.3322\/caac.21499.","journal-title":"CA Cancer J Clin."},{"key":"9951_CR8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/978-3-031-63657-8_10","volume":"1460","author":"A Engin","year":"2024","unstructured":"Engin A. Reappraisal of Adipose Tissue Inflammation in Obesity. Adv Exp Med Biol. 2024;1460:297\u2013327. https:\/\/doi.org\/10.1007\/978-3-031-63657-8_10.","journal-title":"Adv Exp Med Biol."},{"key":"9951_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-3-319-48382-5_9","volume":"960","author":"A Engin","year":"2017","unstructured":"Engin A. The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation. Adv Exp Med Biol. 2017;960:221\u2013245. https:\/\/doi.org\/10.1007\/978-3-319-48382-5_9.","journal-title":"Adv Exp Med Biol."},{"key":"9951_CR10","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017;376:254\u2013266. https:\/\/doi.org\/10.1056\/NEJMra1514009.","journal-title":"N Engl J Med."},{"key":"9951_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/978-1-4939-0897-4_14","volume":"817","author":"Y Sanz","year":"2014","unstructured":"Sanz Y, Moya-P\u00e9rez A. Microbiota, inflammation and obesity. Adv Exp Med Biol. 2014;817:291\u2013317. https:\/\/doi.org\/10.1007\/978-1-4939-0897-4_14.","journal-title":"Adv Exp Med Biol."},{"key":"9951_CR12","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1007\/s11357-024-01375-x","volume":"47","author":"Z Ungvari","year":"2025","unstructured":"Ungvari Z, Fekete M, Varga P et al. Overweight and obesity significantly increase colorectal cancer risk: a meta-analysis of 66 studies revealing a 25\u201357% elevation in risk. Geroscience. 2025;47:3343\u20133364. https:\/\/doi.org\/10.1007\/s11357-024-01375-x.","journal-title":"Geroscience."},{"key":"9951_CR13","doi-asserted-by":"publisher","unstructured":"Safizadeh F, Mandic M, Hoffmeister M, Brenner H. Colorectal Cancer and Central Obesity.\u00a0JAMA Netw Open. 2025;8(1):e2454753. Published 2025 Jan 2. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.54753","DOI":"10.1001\/jamanetworkopen.2024.54753"},{"key":"9951_CR14","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1158\/1940-6207.CAPR-20-0664","volume":"14","author":"CN Santiago","year":"2021","unstructured":"Santiago CN, Rifkin S, Drewes J et al. Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps. Cancer Prev Res (Phila). 2021;14:697\u2013708. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-20-0664.","journal-title":"Cancer Prev Res (Phila)."},{"key":"9951_CR15","doi-asserted-by":"publisher","unstructured":"Comstock SS, Hortos K, Kovan B, McCaskey S, Pathak DR, Fenton JI. Adipokines and obesity are associated with colorectal polyps in adult males: a cross-sectional study.\u00a0PLoS One. 2014;9(1):e85939. Published 2014 Jan 17. https:\/\/doi.org\/10.1371\/journal.pone.0085939","DOI":"10.1371\/journal.pone.0085939"},{"key":"9951_CR16","doi-asserted-by":"publisher","unstructured":"Chaplin A, Rodriguez RM, Segura-Sampedro JJ, Ochogav\u00eda-Segu\u00ed A, Romaguera D, Barcel\u00f3-Coblijn G. Insights behind the Relationship between Colorectal Cancer and Obesity: Is Visceral Adipose Tissue the Missing Link?.\u00a0Int J Mol Sci. 2022;23(21):13128. Published 2022 Oct 28. https:\/\/doi.org\/10.3390\/ijms232113128","DOI":"10.3390\/ijms232113128"},{"key":"9951_CR17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","volume":"62","author":"M Bardou","year":"2013","unstructured":"Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933\u2013947. https:\/\/doi.org\/10.1136\/gutjnl-2013-304701.","journal-title":"Gut."},{"key":"9951_CR18","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.metabol.2015.06.013","volume":"64","author":"YS Yoon","year":"2015","unstructured":"Yoon YS, Keum N, Zhang X, Cho E, Giovannucci EL. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis. Metabolism. 2015;64:1324\u20131333. https:\/\/doi.org\/10.1016\/j.metabol.2015.06.013.","journal-title":"Metabolism."},{"key":"9951_CR19","doi-asserted-by":"publisher","first-page":"5177","DOI":"10.3748\/wjg.v20.i18.5177","volume":"20","author":"S Riondino","year":"2014","unstructured":"Riondino S, Roselli M, Palmirotta R, Della-Morte D, Ferroni P, Guadagni F. Obesity and colorectal cancer: role of adipokines in tumor initiation and progression. World J Gastroenterol. 2014;20:5177\u20135190. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5177.","journal-title":"World J Gastroenterol."},{"key":"9951_CR20","doi-asserted-by":"publisher","unstructured":"Sato Y, Tsujinaka S, Miura T, Kitamura Y, Suzuki H, Shibata C. Inflammatory Bowel Disease and Colorectal Cancer: Epidemiology, Etiology, Surveillance, and Management.\u00a0Cancers (Basel). 2023;15(16):4154. Published 2023 Aug 17. https:\/\/doi.org\/10.3390\/cancers15164154","DOI":"10.3390\/cancers15164154"},{"key":"9951_CR21","doi-asserted-by":"publisher","unstructured":"Casas-Deza D, Garc\u00eda-L\u00f3pez S, Bernal-Monterde V, Polo-Cuadro C, Yag\u00fce-Caballero C, Arbones-Mainar JM. Obesity-Mediated Inflammation and Its Influence on Inflammatory Bowel Disease: Pathophysiology, Clinical Impact, and Therapeutic Implications.\u00a0Biomolecules. 2025;15(8):1185. Published 2025 Aug 18. https:\/\/doi.org\/10.3390\/biom15081185","DOI":"10.3390\/biom15081185"},{"key":"9951_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ajg.2015.65","volume":"110","author":"CH Choi","year":"2015","unstructured":"Choi CH, Rutter MD, Askari A et al. Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview. Am J Gastroenterol. 2015;110:1022\u20131034. https:\/\/doi.org\/10.1038\/ajg.2015.65.","journal-title":"Am J Gastroenterol."},{"key":"9951_CR23","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi P, Concato J, Kemper E et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373\u20131379.","journal-title":"J Clin Epidemiol"},{"key":"9951_CR24","doi-asserted-by":"publisher","unstructured":"Choi W, Woo GH, Kwon TH, Jeon JH. Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction.\u00a0Int J Mol Sci. 2025;26(19):9715. Published 2025 Oct 6. https:\/\/doi.org\/10.3390\/ijms26199715","DOI":"10.3390\/ijms26199715"},{"key":"9951_CR25","doi-asserted-by":"publisher","first-page":"E105","DOI":"10.1152\/ajpendo.00070.2021","volume":"321","author":"HE Kunz","year":"2021","unstructured":"Kunz HE, Hart CR, Gries KJ et al. Adipose tissue macrophage populations and inflammation are associated with systemic inflammation and insulin resistance in obesity. Am J Physiol Endocrinol Metab. 2021;321:E105\u2013E121. https:\/\/doi.org\/10.1152\/ajpendo.00070.2021.","journal-title":"Am J Physiol Endocrinol Metab."},{"key":"9951_CR26","doi-asserted-by":"publisher","unstructured":"Kwaifa IK, Bahari H, Yong YK, Noor SM. Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications.\u00a0Biomolecules. 2020;10(2):291. Published 2020 Feb 13. https:\/\/doi.org\/10.3390\/biom10020291","DOI":"10.3390\/biom10020291"},{"key":"9951_CR27","first-page":"4","volume":"17","author":"JP Bastard","year":"2006","unstructured":"Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17:4\u201312.","journal-title":"Eur Cytokine Netw."},{"key":"9951_CR28","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s11010-023-04670-x","volume":"478","author":"I Akrida","year":"2023","unstructured":"Akrida I, Papadaki H. Adipokines and epithelial-mesenchymal transition (EMT) in cancer. Mol Cell Biochem. 2023;478:2419\u20132433. https:\/\/doi.org\/10.1007\/s11010-023-04670-x.","journal-title":"Mol Cell Biochem."},{"key":"9951_CR29","doi-asserted-by":"publisher","unstructured":"Triantaphyllopoulos KA, Ragia ND, Panagiotopoulou ME, Sourlingas TG. Integrating Inflammatory and Epigenetic Signatures in IBD-Associated Colorectal Carcinogenesis: Models, Mechanisms, and Clinical Implications.\u00a0Int J Mol Sci. 2025;26(19):9498. Published 2025 Sep 28. https:\/\/doi.org\/10.3390\/ijms26199498","DOI":"10.3390\/ijms26199498"},{"key":"9951_CR30","doi-asserted-by":"publisher","unstructured":"Centorrino E, Ferrari D, Harmsen WS, Larson DW, Loftus EV Jr, Coelho-Prabhu N. Undetected Dysplasia at Colectomy in Patients With Inflammatory Bowel Diseases. What Are We Missing?.\u00a0Inflamm Bowel Dis. 2025;31(7):1952\u20131960. https:\/\/doi.org\/10.1093\/ibd\/izae274","DOI":"10.1093\/ibd\/izae274"},{"key":"9951_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","volume":"161","author":"SK Murthy","year":"2021","unstructured":"Murthy SK, Feuerstein JD, Nguyen GC, Velayos FS. AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review. Gastroenterology. 2021;161:1043-1051.e4. https:\/\/doi.org\/10.1053\/j.gastro.2021.05.063.","journal-title":"Gastroenterology."},{"key":"9951_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1016\/j.gie.2019.12.041","volume":"91","author":"ME de Jong","year":"2020","unstructured":"de Jong ME, Kanne H, Nissen LHC, Drenth JPH, Derikx LAAP, Hoentjen F. Increased risk of high-grade dysplasia and colorectal cancer in inflammatory bowel disease patients with recurrent low-grade dysplasia. Gastrointest Endosc. 2020;91:1334-1342.e1. https:\/\/doi.org\/10.1016\/j.gie.2019.12.041.","journal-title":"Gastrointest Endosc."},{"key":"9951_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ijc.28346","volume":"134","author":"U Nieminen","year":"2014","unstructured":"Nieminen U, Jussila A, Nordling S, Mustonen H, F\u00e4rkkil\u00e4 MA. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data. Int J Cancer. 2014;134:189\u2013196. https:\/\/doi.org\/10.1002\/ijc.28346.","journal-title":"Int J Cancer."},{"key":"9951_CR34","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","volume":"160","author":"AM Wijnands","year":"2021","unstructured":"Wijnands AM, de Jong ME, Lutgens MWMD et al. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Gastroenterology. 2021;160:1584\u20131598. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.036.","journal-title":"Gastroenterology."},{"key":"9951_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1053\/j.gastro.2023.06.036","volume":"165","author":"AJ Yarur","year":"2023","unstructured":"Yarur AJ, Bruss A, Moosreiner A et al. Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. Gastroenterology. 2023;165:963-975.e5. https:\/\/doi.org\/10.1053\/j.gastro.2023.06.036.","journal-title":"Gastroenterology."},{"key":"9951_CR36","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nrgastro.2016.181","volume":"14","author":"S Singh","year":"2017","unstructured":"Singh S, Dulai PS, Zarrinpar A, Ramamoorthy S, Sandborn WJ. Obesity in IBD: epidemiology, pathogenesis, disease course and treatment outcomes. Nat Rev Gastroenterol Hepatol. 2017;14:110\u2013121. https:\/\/doi.org\/10.1038\/nrgastro.2016.181.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"9951_CR37","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40259-022-00522-0","volume":"36","author":"M Bassi","year":"2022","unstructured":"Bassi M, Singh S. Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases. BioDrugs. 2022;36:197\u2013203. https:\/\/doi.org\/10.1007\/s40259-022-00522-0.","journal-title":"BioDrugs."},{"key":"9951_CR38","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1007\/s10620-025-09052-5","volume":"70","author":"D Oomkens","year":"2025","unstructured":"Oomkens D, Mujagic Z, de Vries A et al. Obesity Is Associated with Inferior Clinical Treatment Outcomes in Inflammatory Bowel Disease: A Nationwide Dutch Registry Study. Dig Dis Sci. 2025;70:2786\u20132793. https:\/\/doi.org\/10.1007\/s10620-025-09052-5.","journal-title":"Dig Dis Sci."},{"key":"9951_CR39","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1111\/apt.14665","volume":"47","author":"S Kurnool","year":"2018","unstructured":"Kurnool S, Nguyen NH, Proudfoot J et al. High body mass index is associated with increased risk of treatment failure and surgery in biologic-treated patients with ulcerative colitis. Aliment Pharmacol Ther. 2018;47:1472\u20131479. https:\/\/doi.org\/10.1111\/apt.14665.","journal-title":"Aliment Pharmacol Ther."},{"key":"9951_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106320","volume":"182","author":"G Bendotti","year":"2022","unstructured":"Bendotti G, Montefusco L, Lunati ME et al. The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists. Pharmacol Res. 2022;182:106320. https:\/\/doi.org\/10.1016\/j.phrs.2022.106320.","journal-title":"Pharmacol Res."},{"key":"9951_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/apt.70485","volume":"63","author":"B Maracle","year":"2026","unstructured":"Maracle B, Quan S, Hamilton P et al. Systematic Review: Efficacy, Safety and Metabolic Outcomes of GLP-1 Receptor Agonists in Inflammatory Bowel Disease. Aliment Pharmacol Ther. 2026;63:17\u201339. https:\/\/doi.org\/10.1111\/apt.70485.","journal-title":"Aliment Pharmacol Ther."},{"key":"9951_CR42","doi-asserted-by":"publisher","unstructured":"Bayoumy AB, Clarke LM, Deepak P, et al. Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.\u00a0J Crohns Colitis. 2025;19(10):jjaf181. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaf181","DOI":"10.1093\/ecco-jcc\/jjaf181"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09951-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09951-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:14:10Z","timestamp":1787800450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09951-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9951"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09951-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was reviewed and approved by the Institutional Review Board of NYU Grossman School of Medicine. Given the retrospective design and use of deidentified data, the requirement for informed consent was waived.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}